Neogenomics NEO
NASDAQ NEO
$19.41 +0.00 (+0.00%)
As of: Sep 22, 2026 · 10:04 AM EDT

Neogenomics (NEO) Research & Development (2010 - 2026)

Neogenomics' (NEO) quarterly Research & Development came in at $27.3 million in Q2 2026, up 13.29% on a YoY basis from $24.1 million in Q2 2025, and up 14.46% quarter-over-quarter from $23.8 million in Q1 2026.

Analysis

Neogenomics (NEO) Research & Development (2010 - 2026) Analysis & Trends

Neogenomics (NEO) has reported Research & Development for 17 consecutive years, with $27.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Research & Development rose 13.29% year-over-year to $27.3 million; the trailing twelve-month figure through Jun 2026 stood at $96.4 million (up 7.64% YoY), and the FY2025 full-year result was $92.0 million, up 8.69% from the prior year.
  • Research & Development rose to $27.3 million in Q2 2026 per NEO's latest filing, from $23.8 million in the prior quarter.
  • Across five years, Research & Development topped out at $27.3 million in Q2 2026 and bottomed at $16.3 million in Q1 2023.
  • Historically, Research & Development has averaged $20.3 million across 5 years, with a median of $20.3 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Research & Development slipped 0.89% in 2022, then grew 24.37% in 2024.
  • Over 5 years, Research & Development stood at $17.1 million in 2022, then advanced by 5.43% to $18.1 million in 2023, then rose by 23.61% to $22.3 million in 2024, then increased by 4.94% to $23.4 million in 2025, then gained by 16.35% to $27.3 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods registered $27.3 million, $23.8 million, and $23.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn 228.07 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn -
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn -
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn 189.95 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn 52.64 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn 53.76 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn -
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn 17.32 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn 26.41 Mn
10 Neogenomics 2.55 Bn 2.40 Bn 91.88 Mn 27.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27.28 Mn
Mar 31, 2026 23.83 Mn
Dec 31, 2025 23.44 Mn
Sep 30, 2025 21.81 Mn
Jun 30, 2025 24.08 Mn
Mar 31, 2025 22.68 Mn
Dec 31, 2024 22.34 Mn
Sep 30, 2024 20.42 Mn
Jun 30, 2024 21.68 Mn
Mar 31, 2024 20.22 Mn
Dec 31, 2023 18.07 Mn
Sep 30, 2023 17.61 Mn
Jun 30, 2023 18.90 Mn
Mar 31, 2023 16.26 Mn
Dec 31, 2022 17.14 Mn
Sep 30, 2022 16.81 Mn
Jun 30, 2022 17.07 Mn
Mar 31, 2022 16.30 Mn
Dec 31, 2021 15.92 Mn
Sep 30, 2021 15.70 Mn
API Access

Neogenomics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=NEO&period=max&api_key=YOUR_API_KEY